| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |